Objective: To investigate the relationship between alcohol intake and serum level of high-density lipoprotein (HDL) subfractions de®ned on the basis of their apolipoprotein A-I and A-II content (LpA-I and LpA-I:A-II). Design: Observational study.
Introduction
Observational studies suggest that moderate consumption of alcoholic beverages is associated with a reduced risk of cardiovascular death (Jackson et al, 1993; Criqui & Ringel, 1994) . The reasons are poorly understood. Alcohol intake has been shown to be positively associated with serum concentration of high density lipoprotein (HDL) cholesterol (Burr et al, 1986; Hagiage et al, 1992; Va Èlima Èki et al, 1991; Williams et al, 1985) . Since there is an inverse relationship between HDL-cholesterol (HDL-C) and cardiovascular risk (Gordon & Rifkind, 1989; Stampfer et al, 1991) an alcohol induced increase of HDL-C might provide a potential explanation for the protective effect of alcohol.
HDLs comprise an extremely heterogeneous family of lipoproteins that vary in size, density, lipid and apolipoprotein (apo) composition, metabolic functions and clinical signi®cance. On the basis of their density, HDLs are currently divided into two main subclasses, HDL 2 and HDL 3 (Eisenberg, 1984) and the alcohol induced increase in HDL-C has been shown to be mainly due to the increase of the HDL 3 subfraction (Haskel et al, 1984; Va Èlima Èki et al, 1991; Williams et al, 1985) which is believed to be less antiatherogenic than HDL 2 (Miller et al, 1981) .
On the other hand, alcohol intake is associated with an increase of both apo A-I and apo A-II (Hartung et al, 1990; Va Èlima Èki et al, 1991; Williams et al, 1985) and the two apoproteins de®ne different HDL particles which overlap with the density de®ned HDL subfractions (James & Pometta, 1990) . At least two main subclasses of HDLs can be identi®ed, the ®rst one is characterized by the presence in the lipoprotein molecule of apo A-I (LpA-I) and the second one by the presence of both apo A-I and apo A-II (LpA-I:A-II). The studies performed to date on the effects of ethanol intake on apo A-de®ned HDL provided con¯icting results (Clevidence et al, 1995; Fruchart et al, 1993; Puchois et al, 1990; Steinmetz et al, 1990; Va Èlima Èki et al, 1991; Va Èlima Èki et al, 1993) . Because the two apo Ade®ned HDL particles seem to have different antiatherogenic properties (Cheung et al, 1991; Genest et al, 1991; Puchois et al, 1987; Takata et al, 1990) , we believed that it was of interest to further evaluate whether ethanol intake was associated with different levels of the two HDL subpopulations.
Material and methods
The study was carried out on 100 males randomly selected among blood donors in whom clinical and laboratory examination did not demonstrate liver abnormalities and the presence of acute and chronic illnesses. Their age ranged from 20±67 y with a mean of 42 y (s.d. 11.07). Body mass index (BMI, Kg/m 2 ) ranged from 20±36.9 with a mean of 25.5 (s.d. 3.41) . None of the subjects was taking drugs known to affect lipid metabolism.
Subjects were interviewed about smoke habit, physical activity and habitual use of alcoholic beverages by one of us (CT). In particular, the subjects were asked about the usual daily intake of wine, beer and hard liquors during and between meals. Grams of alcohol consumed per day were calculated on the basis of 10.5 g per 120 ml glass of wine, 10.5 g per 330 ml bottle of beer and 9.6 g per 30 ml glass of hard liquor. Thirty ®ve subjects were teetotallers and 65 consumed alcoholic beverages, mostly wine, in amounts ranging from 11±124 g of alcohol per day. All of them had been drinking up to within the day before the study. In addition, a 24 h dietary recall was obtained. The nutrient intake was calculated by using a computerized nutrient database (Nutritest, Scotti-Bassani Foundation, Milan, Italy), derived from tables of food composition of the National Institute of Nutrition (Carnovale & Miuccio, 1989) . Daily intake was determined for carbohydrates, fat and protein.
Blood samples were collected and immediately centrifuged in the morning after an overnight fast. Lp A-I was quanti®ed by a differential electroimmunoassay (Sebia, Issy-les-Moulineaux, France), and Lp A-I:A-II was calculated as the difference between the apo A-I in whole serum and the apo A-I in Lp A-I. Apo A-I and apo A-II were determined via nephelometry (Dasit Orion, S.p.A., Bareggio, Italy). The intraassay coef®cient of variation was 3.19% for Lp A-I, 2.78% for apo A-I, and 3.05% for apo A-II. The interassay coef®cients of variation were 7.48%, 6.92% and 6.28%, respectively. HDL was separated by precipitating apo B-containing lipoproteins with phosphotungstate/magnesium (Boehringer Mannheim Italia S.p.A., Milan, Italy). Serum cholesterol and HDL-C levels were measured by using the CHOD-PAP method, and serum triglycerides by using the GPO-PAP method (Boehringer Mannheim Italia S.p.A., Milan, Italy).
Data were compared by analysis of variance (ANOVA) and by calculating the 95% con®dence intervals (C.I.). Simple univariate correlations were used to evaluate the relationship among anthropometric data, dietary items and lipoprotein variables. Separate multiple linear regression models (backward stepwise regression) examined HDL, apolipoproteins A and apo A-de®ned HDL particles as dependent variables and age, BMI, serum cholesterol, serum triglycerides, dietary variables and alcohol as independent variables. Chi square was used to compare discrete variables.
Results
According to the ethanol use, the subjects were divided into three groups, the ®rst one of non-drinkers, the second one of light-moderate drinkers (less than 30 g of ethanol a day) and the third one of heavy drinkers (more than 30 g of ethanol a day). Table 1 shows mean values of age, BMI, macronutrient diet composition and alcohol intake in the three groups of subjects subdivided according to the alcohol use. Age was signi®cantly different among the groups, and the heavy drinkers had the highest mean age, as it is not infrequent in our country. In this last group, the daily protein intake was signi®cantly greater than in the other two groups. Cigarette smoking was not statistically different among the groups (22% of non drinkers, 31% of light-moderate drinkers and 22% of heavy drinkers smoked, chi square 0.995, P NS). A moderate physical activity was reported by 49% of nondrinkers, by 20% of light-moderate drinkers and by 8% of heavy drinkers (chi square 3.652, P NS).
Serum triglycerides and cholesterol did not signi®cantly differ among the groups, while HDL-C, apo A-I, apo A-II and Lp A-I:A-II resulted to be signi®cantly different ( Table  2 ). The direct comparison demonstrated that heavy drinkers had HDL-C signi®cantly higher than non drinkers (difference between means 7.0 mg/dL, 95% C.I. 2.49±11.5) and than light-moderate drinkers (difference between means 7.6 mg/dL, 95% C.I. 2.58±12.6). In heavy drinkers, both apo A-I and apo A-II were signi®cantly higher than in non drinkers (apo A-I: difference between means 18.0 mg/dL, 95% C.I. 5.52±30.5; apo A-II: difference between means 4.6 mg/dL, 95% C.I. 1.75±7.45) and apo A-I, but not apo A-II was higher than in light-moderate drinkers (apo A-I: difference between means 15.4 mg/dL, 95% C.I. 2.42± 28.4; apo A-II: difference between means 2.8 mg/dL, 95% C.I. 75.72±0.118). Lp A-I:A-II was also signi®cantly higher in heavy drinkers than in non drinkers (difference between means 11.5 mg/dL, 95% C.I. 0.52±22.5) and than in light-moderate drinkers (difference between means 11.8 mg/dL, 95% C.I. 0.97±22.6). Although the analysis of variance failed to demonstrate a signi®cant difference in Lp A-I levels among the groups (Table 2) , the direct comparison of the mean values of Lp A-I in heavy drinkers and in non-drinkers showed a statistically signi®cant difference (difference between means 6.5 mg/dL, 95% C.I. 1.14±11.9). HDL-C, apoproteins A and HDL subfractions were not different in light-moderate drinkers with respect to non drinkers.
Alcohol consumption resulted to be signi®cantly correlated with HDL-C (r 0.25, P`0.05), apo A-I (r 0.25, P`0.05), apo A-II (r 0.28, P`0.01) and Lp A-I:A-II (r 0.20, P`0.05), but not with Lp A-I (r 0.18, P NS). HDL-C was inversely related to BMI (r 70.23, P`0.05) and to serum triglycerides (r 70.40, P`0.001) and apo A-I, apo A-II and Lp A-I:A-II were signi®cantly correlated with age (r 0.20, P b 0.05, r 0.27, P`0.01 and r 0.20, P`0.05, respectively).
Because of the correlation of the different variables, we ran a backward stepwise regression analysis with HDL-C, apo A-I, apo A-II, Lp A-I and Lp A-I:A-II levels as dependent variables and age, BMI, serum cholesterol, serum triglycerides, diet composition and ethanol intake as independent variables. In these analysis, the most consistent association was alcohol which was positively associated with HDL-C (partial F 10.80, P`0.01), apo A-I (partial F 6.78, P`0.01), apo A-II (partial F 8.44, P`0.01), Lp A-I (partial F 8.95, P`0.01) and Lp A-I:A-II (partial F 5.27, P`0.01).
Discussion
Results of the present study show that alcohol intake is associated with an increase of HDL-C, apo A-I and apo A- (Eisenberg, 1984) . Our data are then in accord with previous studies which showed that drinkers have higher serum level of HDL-C, apo A-I and apo A-II than non drinkers (Burr et al, 1986; Williams et al, 1985) . Accordingly, Hagiage et al (1992) and Va Èlima Èki et al (1991) demonstrated that HDL-C, apo A-I and apo A-II increase after 2±3 weeks of alcohol intake and return toward baseline levels after cessation of alcohol. While there is a general agreement on the effects of alcohol in increasing serum level of HDL-C and of apoproteins A-I and A-II, con¯icting results have been reported in the few studies addressed to apo A-de®ned HDL subpopulations. Steinmetz et al (1990) did not observe a signi®cant difference in LpA-I level between males drinking more or less than 44 g of alcohol a day and between females drinking more or less than 22 g of alcohol a day. Va Èlima Èki et al (1991) and Clevidence et al (1995) found an increase in serum concentration of both LpA-I and LpA-I:A-II during ethanol intake. A signi®cant decrease of the two lipoprotein subfractions has been reported by Va Èlima Èki et al (1993) in alcoholic women after ethanol withdrawal. In contrast, Hagiage et al (1992) reported a signi®cant increase of LpA-I, but not of LpA-I:A-II in subjects drinking 30 g of alcohol a day for 14 d. Puchois et al (1990) in a study on con®rmed drinkers found that alcohol intake was positively associated with LpA-I:A-II and negatively associated with LpA-I serum concentration. Similarly, Fruchart et al (1993) observed that chronic alcohol consumption induces an increase in LpA-I:A-II and a decrease in LpA-I. The authors, however, observed that short bouts of drinking produced an increase in both the lipoproteins.
In our series of subjects, LpA-I and LpA-I:A-II levels were positively correlated with alcohol consumption and the mean serum concentration of both LpA-I and LpA-I:A-II was signi®cantly higher in subjects drinking more than 30 of alcohol a day than in non-drinkers. The studies reported so far differ in design, duration and amount of alcohol intake and this may be of relevance in explaining the different results. However, all studies but one (Hagiage et al, 1992) show that alcohol consumption is mainly associated with an increase of LpA-I:A-II (Clevidence et al, 1995; Fruchart et al, 1993; Steinmetz et al, 1990 Va Èlima Èki et al, 1991 Va Èlima Èki et al, 1993 . In our study too, the difference in LpA-I:A-II level between drinkers and non drinkers is much greater than the difference in LpA-I and in both univariate and multivariate analysis, the association between alcohol and LpA-I:A-II is stronger than the association between alcohol and LpA-I. This is consistent with the preferential increase of HDL 3 subfraction induced by ethanol (Haskel et al, 1984; Va Èlima Èki et al, 1991; Williams et al, 1985) , since the majority of LpA-I:A-II resides in the HDL 3 density range (James & Pometta, 1990) .
Clinical studies have shown an inverse relationship between LpA-I and coronary heart disease risk (Cheung et al, 1991; Genest et al, 1991; Puchois et al, 1987) . LpA-I is more effective than LpA-I:A-II in promoting cholesterol ef¯ux from incubated cells (Barbaras et al, 1987; Huang et al, 1995; Johnson et al, 1991) . These observations have led to the conclusion that the antiatherogenic properties of HDL are due only to LpA-I. However, patients with coronary heart disease have serum LpA-I:A-II level also lower than control subjects (Montali et al, 1994) and recent studies showed that LpA-I and LpA-I:A-II are equally effective in promoting cholesterol ef¯ux from cultured cells (Oikawa et al, 1993) . Thus it would be inappropriate to conclude that LpA-I has a predominant role as antiatherogenic factor. In any case, the present study as well as previous studies (Clevidence et al, 1995; Va Èlima Èki et al, 1991; Va Èlima Èki et al, 1993) , suggest that alcohol intake is associated with an increase of both LpA-I and LpA-I:A-II and this might explain, at least in part, the protective effect of alcohol consumption on cardiovascular mortality. 
